Trial reportObesity surgery2026
Omentopexy Effect on Gastric Dilatation Post Laparoscopic Sleeve Gastrectomy: A Randomized Controlled Trial.
Trial report in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity is a global health crisis. Bariatric surgeries not only induce weight loss but also help in remission of these associated medical problems. Among the various bariatric procedures, laparoscopic sleeve gastrectomy (LSG) has become the most performed procedure worldwide. However, LSG has its own adverse effects. Suboptimal clinical response and recurrent weight gain are among the most challenging sequelae after surgery. Omentopexy is a novel step added to the conventional LSG. Our study aimed to assess the effect of omentopexy on gastric sleeve dilation following LSG and its impact on weight loss after surgery.
methodsThis study included 100 patients who were recruited for LSG divided into 2 groups. Patients were randomly enrolled into the non-omentopexy group (underwent LSG without omentopexy) and the omentopexy group (underwent LSG with omentopexy). Gastric volumetry using 3D gastric computed tomography were done for all patients at Day 1, 6 month and 1 year after the operation.
resultsThere was no significant difference between the 2 groups at postoperative Day 1 (p = 0.12) regarding the sleeve volumetry. However, after 6 months and 12 months, the non-omentopexy group showed significantly greater volume increase (p < 0.001), there was no significant correlation between gastric sleeve volume and the EWL% and TWL% in Non-omentopexy and Omentopexy groups.
conclusionOmentopexy step, although adds more to the operative time, but it may serve as a guard against postoperative sleeve dilation by stabilizing the staple line which can be a major role in maintaining sufficient weight loss and prevents recurrent weight gain on the long term.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.